ASF1B promotes gastric cancer progression by modulating H2AC20 and activating PI3K/AKT and ERK1/2 pathways
BackgroundGastric cancer (GC) ranks among the most prevalent malignant neoplasms globally and is associated with a significant mortality rate. Despite the availability of various therapeutic interventions for GC, the overall prognosis for this disease remains unfavorable. This can be attributed to s...
Saved in:
| Main Authors: | Mengyuan Zhao, Junchang Zhang, Yanjun He, Chongge You |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1533257/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CCL20 Expression via AKT-ERK1/2-AP1 Pathway in Mycoplasma Pneumoniae Infection: Implications for EMT and Cell Migration
by: Yang X, et al.
Published: (2025-04-01) -
The role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications
by: Hanlin Xu, et al.
Published: (2025-05-01) -
Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor
by: Xiao‐Xiao Li, et al.
Published: (2018-09-01) -
Isomeric 3-Pyridinylmethylcoumarins Differ in Erk1/2-Inhibition and Modulation of BV2 Microglia-Mediated Neuroinflammation
by: Rami Schulzki, et al.
Published: (2025-06-01) -
PLCH1 overexpression promotes breast cancer progression and predicts poor prognosis through the ERK1/2-EGR1 axis
by: Jing Li, et al.
Published: (2025-05-01)